Brazil is the largest country in South America both in terms of population and area, while the country ranks fifth in the world in terms of territory. About 200 million people live in the country, the average life expectancy as of 2019 was 75.7 years, Portuguese is official language. Healthcare in Brazil at the present stage occupies a rightful place in the ranking of world health care systems. Not much is allocated for healthcare needs according to the European standards — about 8.5 % of GDP. However 1 % from any banking transaction in the country goes for medicine. At the same time the state pays close attention to health issues, fully providing financing for such costly areas as the treatment of HIV-associated pathology and hepatitis C, hemodialysis, and insulin therapy. But it was not always this way. Until 1988, before the right of all citizens to receive guaranteed medical care was enshrined in the Brazilian Constitution, healthcare in the country was available only to wealthy segments of the population, while the poor could only rely on the provision of medical services as part of charity. National Health System was established in the country in 1990 due to the adoption of the Constitution, which proclaimed the right to health as one of the fundamental human rights. Today, this system is one of the largest public health systems in the world, which covers provision of health care for about 200 million people. The country moved from the category of «recipient» of medical care at the world level to the category of «donor» not so long ago, and is very successful in this. This is one of the few states where public health interests of the nation are put above economic ones. This fact was confirmed during the tobacco control company. Brazil, being a major exporter of tobacco products, took an active part in this company, despite the fact that it suffered major economic losses [1].